Lumos Diagnostics Holdings Ltd. (AU:LDX) has released an update.
Lumos Diagnostics Holdings Ltd. has reported a change in Director Sam Lanyon’s interest, with an on-market acquisition of 250,000 fully paid ordinary shares at a total value of $7,500. This transaction, dated June 7, 2024, increases Lanyon’s indirect holdings in the company, via accounts where he is a beneficiary, to 591,401 shares, alongside 2,246,500 unquoted options.
For further insights into AU:LDX stock, check out TipRanks’ Stock Analysis page.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
